These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6748309)

  • 1. [Decrease in serum apoprotein A-IV levels in patients with chronic pancreatitis, diabetes mellitus and malabsorption syndrome].
    Miyata Y; Koga T; Funakoshi A; Ibayashi H
    Nihon Shokakibyo Gakkai Zasshi; 1984 Mar; 81(3):928. PubMed ID: 6748309
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma apolipoprotein A-IV levels decrease in patients with chronic pancreatitis and malabsorption syndrome.
    Koga S; Miyata Y; Funakoshi A; Ibayashi H
    Digestion; 1985; 32(1):19-24. PubMed ID: 4018439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in plasma levels of apolipoprotein A-IV in various clinical entities.
    Miyata Y; Koga S; Ibayashi H
    Gastroenterol Jpn; 1986 Oct; 21(5):479-85. PubMed ID: 3781171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the inflammation, chronic hyperglycemia, or malabsorption on the apolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis.
    Quilliot D; Walters E; Guerci B; Fruchart JC; Duriez P; Drouin P; Ziegler O
    Metabolism; 2001 Sep; 50(9):1019-24. PubMed ID: 11555832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid abnormalities in chronic pancreatitis: effect of concomitant diabetes mellitus.
    Quilliot D; Walters E; Böhme P; Lacroix B; Bonte JP; Fruchart JC; Drouin P; Duriez P; Ziegler O
    Eur J Clin Nutr; 2003 Mar; 57(3):496-503. PubMed ID: 12627189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid malabsorption as a cause of hypocholesterolemia seen in patients with chronic pancreatitis.
    Nakamura T; Takebe K; Yamada N; Arai Y; Tando Y; Terada A; Ishii M; Kikuchi H; Machida K; Imamura K
    Int J Pancreatol; 1994; 16(2-3):165-9. PubMed ID: 7868942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoprotein and apoprotein changes in type-2 diabetes mellitus].
    Dobrev D; Terzieva Ts; Krŭstev I; Petrova V; Ivanov I
    Vutr Boles; 1988; 27(5):24-8. PubMed ID: 3213033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunopathological changes in patients with chronic pancreatitis and diabetes mellitus].
    Sidorov KA; Mitropol'skiĭ AN
    Ter Arkh; 1968 Jan; 40(1):98-103. PubMed ID: 4988968
    [No Abstract]   [Full Text] [Related]  

  • 9. Elevated levels of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with malabsorption syndrome.
    Nakano I; Funakoshi A; Kimura T; Miyata Y; Koga S; Ibayashi H
    Gastroenterol Jpn; 1986 Dec; 21(6):617-22. PubMed ID: 2436966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipoproteins in diabetes secondary to chronic calcific pancreatitis.
    Joffe BI; Tim LO; Mendelsohn D; Segal I; Seftel HC
    Horm Metab Res; 1981 May; 13(5):298-9. PubMed ID: 7262829
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum insulin levels in patients with chronic pancreatitis.
    Rogers JB; Howard JM; Pairent FW
    Am J Surg; 1970 Feb; 119(2):171-6. PubMed ID: 5440786
    [No Abstract]   [Full Text] [Related]  

  • 12. Secretin secretion in patients with duodenal ulcer, chronic pancreatitis and diabetes mellitus.
    Ohara H; Inabe S; Yabu-uchi S; Ohta H; Wada T
    Gastroenterol Jpn; 1978; 13(1):21-7. PubMed ID: 648803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plasma insulin in chronic pancreatitis].
    Azerad E; Bernier JJ; Lubetzki J; Duprey J; Friedler D; Croisier JC
    Diabete; 1967; 15(4):269-74. PubMed ID: 5634172
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diabetes mellitus in patients with chronic alcoholic pancreatitis].
    Sadokov VM; Vinokurova LV
    Ter Arkh; 1993; 65(10):27-9. PubMed ID: 8296228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha2-macroglobulin concentration in the serum in chronic pancreatitis, liver cirrhosis and diabetes mellitus].
    Geller LI; Kazimirchik AP; Kozlova ZP
    Vopr Med Khim; 1973; 19(1):96-9. PubMed ID: 4788012
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quantitative characterization of the main lipid and apoprotein components of plasma lipoproteins in men with types I and II diabetes mellitus with and without coronary heart disease].
    Madanat AIa; Slavina LS; Perova NV; Metel'skaia VA; Zholus NP
    Ter Arkh; 1987; 59(11):18-22. PubMed ID: 3441860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intravenous tolbutamide on serum insulin levels in pancreatic diabetes.
    Joffe BI; Bank S; Jackson WP; Vinik AI; Keller P
    Diabetes; 1969 Jul; 18(7):499-501. PubMed ID: 5795033
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma apoproteins and the severity of coronary artery disease.
    Sedlis SP; Schechtman KB; Ludbrook PA; Sobel BE; Schonfeld G
    Circulation; 1986 May; 73(5):978-86. PubMed ID: 3084125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon responses to secretion and CCK-PZ in diabetes and chronic pancreatitis.
    Kalk WJ; Vinik AI; Jackson WP
    Horm Metab Res; 1978 Nov; 10(6):562. PubMed ID: 744578
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetic microangiopathy in patients with pancreatitic diabetes mellitus.
    Verdonk CA; Palumbo PJ; Gharib H; Bartholomew LG
    Diabetologia; 1975 Oct; 11(5):394-400. PubMed ID: 1181665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.